Sugi Predict

Sugi Predict / Compounds / SCHEMBL18372153

SCHEMBL18372153

SCHEMBL18372153

O=P(c1ccc(-c2ccc3c4ccc(-c5ccc(P(=O)(c6ccc7ccc8cccnc8c7n6)c6ccc7ccc8cccnc8c7n6)cc5)cc4c4ccccc4c3c2)cc1)(c1ccc2ccc3cccnc3c2n1)c1ccc2ccc3cccnc3c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 5/20 0.39
▸ CCR8 P51685 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ CCR5 P51681 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MMP2 P08253 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ GMNN O75496 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18372028 0.90 MAPT (0.43) CCR1CCR8MAPTCCR5LMNA
SCHEMBL20108841 0.84 CCR1 (0.46) CCR1CCR8MAPTCCR5LMNA
SCHEMBL24470385 0.84 KDM4E (0.40) CCR1CCR8MAPTCCR5LMNA
SCHEMBL21123257 0.81 CCR1 (0.36) CCR1CCR8MAPTCCR5LMNA
SCHEMBL11990948 0.81 LMNA (0.52) CCR1CCR8MAPTCCR5LMNA
SCHEMBL21123213 0.81 ECE1 (0.37) CCR1CCR8MAPTCCR5LMNA
SCHEMBL21123043 0.79 ECE1 (0.39) CCR1CCR8MAPTCCR5LMNA
SCHEMBL21123253 0.79 MAPT (0.35) CCR1CCR8MAPTCCR5LMNA
SCHEMBL24470192 0.79 CA1 (0.37) MAPTLMNAKDM4ETP53HTT
SCHEMBL18372166 0.79 CA1 (0.37) MAPTLMNAKDM4ETP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10211404-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-02-19 — — US disclosed
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-12 — — US disclosed
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE PIEZO1, TERT, TPR CCR1 3847/4885CCR8 2887/4885MAPT 1255/4885
US-10211404-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device PIEZO1, TERT, TPR CCR1 3847/4885CCR8 2887/4885MAPT 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.